New Key Statistics Module, Z-Score and F-Score
AMEX:AIM Key Ratios
Market Cap $ M | 21.73 |
Enterprise Value $ M | 10.07 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.21 |
Price/Sales | 107.05 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.60 |
Beneish M-Score | -7.56 |
10-y EBITDA Growth Rate % | 43.10 |
5-y EBITDA Growth Rate % | 40.10 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.32 |
EV-to-EBITDA | -0.32 |
PEG | -- |
Shares Outstanding M | 50.75 |
Net Margin (%) | -14,337.62 |
Operating Margin % | -15,800.50 |
Pre-tax Margin (%) | -14,337.62 |
Quick Ratio | 1.68 |
Current Ratio | 1.68 |
ROA % (ttm) | -91.19 |
ROE % (ttm) | -106.14 |
ROIC % (ttm) | -616.30 |
Dividend Yield % | -- |
Altman Z-Score | -32.71 |
AIM Number of Guru Trades
AIM Volume of Guru Trades
Gurus Latest Trades with AMEX:AIM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:AIM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AIM ImmunoTech Inc Insider Transactions
No Available Data
News about AMEX:AIM
Total 0- 1